- Home
- SHIP vs CRBU Comparison
SHIP vs CRBU Comparison
Compare SHIP & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- CRBU
- Stock Information
- Founded
- SHIP 2008
- CRBU 2011
- Country
- SHIP Greece
- CRBU United States
- Employees
- SHIP N/A
- CRBU N/A
- Industry
- SHIP Marine Transportation
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- SHIP Consumer Discretionary
- CRBU Health Care
- Exchange
- SHIP Nasdaq
- CRBU Nasdaq
- Market Cap
- SHIP 140.8M
- CRBU 151.2M
- IPO Year
- SHIP 2007
- CRBU 2021
- Fundamental
- Price
- SHIP $7.11
- CRBU $1.52
- Analyst Decision
- SHIP Strong Buy
- CRBU Strong Buy
- Analyst Count
- SHIP 2
- CRBU 5
- Target Price
- SHIP $12.50
- CRBU $11.80
- AVG Volume (30 Days)
- SHIP 239.5K
- CRBU 1.6M
- Earning Date
- SHIP 03-14-2025
- CRBU 03-10-2025
- Dividend Yield
- SHIP 14.57%
- CRBU N/A
- EPS Growth
- SHIP N/A
- CRBU N/A
- EPS
- SHIP 2.36
- CRBU N/A
- Revenue
- SHIP $165,210,000.00
- CRBU $11,475,000.00
- Revenue This Year
- SHIP $52.75
- CRBU N/A
- Revenue Next Year
- SHIP $1.07
- CRBU N/A
- P/E Ratio
- SHIP $3.00
- CRBU N/A
- Revenue Growth
- SHIP 66.32
- CRBU N/A
- 52 Week Low
- SHIP $6.55
- CRBU $1.50
- 52 Week High
- SHIP $13.19
- CRBU $8.33
- Technical
- Relative Strength Index (RSI)
- SHIP 45.88
- CRBU 34.82
- Support Level
- SHIP $6.83
- CRBU $1.50
- Resistance Level
- SHIP $7.50
- CRBU $1.69
- Average True Range (ATR)
- SHIP 0.27
- CRBU 0.13
- MACD
- SHIP 0.09
- CRBU -0.01
- Stochastic Oscillator
- SHIP 58.95
- CRBU 3.70
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship among others.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.